Compare CVS Health Corp (CVS) vs Flagstar Bank NA (FLG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Flagstar Bank NA — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Flagstar Bank NA trades at $11.32 (market cap $4.71B). The key difference: CVS Health Corp is far larger — about 23.8× Flagstar Bank NA's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Flagstar Bank NA for 22 Days on average.
| CVS | FLG | |
|---|---|---|
Market Cap | $112.29B | $4.71B |
Volume | 7,763,676 | 7,410,589 |
Sector | Health | Financials |
52-Week High | $110.60 | $15.36 |
52-Week Low | $70.08 | $10.72 |
Typical Hold Time | 83 Days | 22 Days |
Enterprise Value | $174.64B | $15.25B |
Dividend Yield | 3.03% | 0.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% on the day, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07B in 2025, though net income margin compressed to 1.18%. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.
CVS presents a mixed outlook with solid revenue growth and analyst bullishness (85% buy ratings, $111.20 consensus target) offset by profitability pressures and a bearish technical trend. Key risks include reimbursement pressure and ongoing legal investigations, but the stock offers value with a low P/S of 0.27 and dividend yield support.
FLG trades at $11.35, up 0.44% with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals with a high P/E of 378.33 but trades below book value at P/B of 0.62. Recent Q2 2026 earnings missed expectations, though the company announced a $250 million share repurchase program and maintains a dividend. Analyst consensus remains bullish with a $17.07 price target.
FLG presents a turnaround opportunity with improving profitability from 2025 losses to 2026 projected net income of $48 million. Key risks include volatile cash flows and competitive banking pressures. The stock's discount to book value and strong analyst support suggest potential upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →
